UNSPSC 51422113: Diflucortolone pivalate

This classification denotes a therapeutic glucocorticoid C27H36F2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZR05N78276, chemically known as pregna-1,4-diene-3,20-dione, 21-(2,2-dimethyl-1-oxopropoxy)-6,9-difluoro-11-hydroxy-16-methyl-, (6.alpha.,11.beta.,16.alpha.)-, but more generally known as diflucortolone pivalate, which bears US NIH Compound Identifier 66381. Most nations, for tariff and trade purposes, schedule diflucortolone pivalate under HS 29372200 and SITC 54153.

As of Q4 2014, DIFLUCORTOLONE PIVALATE remains US FDA's Preferred Term for this commodity. Diflucortolone pivalate bears US NLM identifiers UMLS ID C0770953 and NCI Concept Code C65383. SMILES: C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@H]1C(=O)COC(=O)C(C)(C)C)C)O)F)C)F.

UNSPSC 51422113 Diflucortolone pivalate is a Commodity code for a topical corticosteroid pharmaceutical product, but recent state and local procurement activity under this code shows minimal relevant purchasing. The single recent opportunity on record—Seminole County, Florida's IFB60459723LAS posted June 30, 2026—is tagged to this code but solicits naloxone and drug deactivation systems for community health initiatives, work that falls outside the pharmaceutical scope of diflucortolone pivalate. The mismatch suggests either a classification error in the opportunity record or a vendor-portal miscoding by the issuing body.

Without concrete recent solicitations aligned to the code's actual pharmaceutical scope, characterizing the geographic spread, issuing-body mix, or active market demand is not supported by the source material. The code shows no substantive recent state and local activity for the product itself.